Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-02-05 / Cancer Immunol Res 2014 May;2(5):404-9Immunotherapy in lung cancer
/in International Publications, NSCLC, SCLC /von 2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):53-63Fighting fire with fire: the revival of thermotherapy for gliomas
/in Glioblastoma, Hyperthermia, International Publications /von 2014-02-01 / Anticancer Res. 2014 Feb;34(2):565-74Immunotherapy prospects in the treatment of lung cancer and mesothelioma
/in International Publications, Malignant Pleural Mesothelioma, NSCLC, SCLC /von 2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):34-45Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2014-01-13 / Hum Vaccin Immunother 2014;10(4):970-6Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses
/in International Publications, Newcastle Disease Virus /von 2014-01-06 / Oncoimmunology 2014 Jan;3(1):e27622Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
/in Dendritic Cells, International Publications /von 2014-01-03 / Cancer Immunol. Immunother. 2014 Apr;63(4):321-33Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection
/in International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2014-01-03 / Cancer Gene Ther. 2014 Jan;21(1):24-30Diffuse intrinsic pontine glioma: time for therapeutic optimism
/in Brain Tumors in Children, International Publications /von 2014-01-01 / CNS Oncol 2014;3(5):337-48IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de